SPY330.65-3.73 -1.12%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Oppenheimer Maintains Outperform on Acceleron Pharma, Raises Price Target to $115

Oppenheimer maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $112 to $115.

Benzinga · 05/12/2020 12:08

Oppenheimer maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $112 to $115.